Ubiquilin/Dsk2 promotes inclusion body formation and vacuole (lysosome)-mediated disposal of mutated huntingtin

Molecular Biology of the Cell

Volumn 27, Issue 13, 2016, Pages 2025-2036

  Chuang, Kun Han ^a   Liang, Fengshan ^a,b   Higgins, Ryan ^a   Wang, Yanchang ^a  

^a FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DSK2 PROTEIN; HUNTINGTIN; MUTANT PROTEIN; POLYGLUTAMINE; UBIQUITINATED PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; CELL CYCLE PROTEIN; DSK2 PROTEIN, S CEREVISIAE; NUCLEAR PROTEIN; PROTEASOME; SACCHAROMYCES CEREVISIAE PROTEIN; UBIQUITIN;

ARTICLE; AUTOPHAGY; CELL INCLUSION; CELL VACUOLE; CONTROLLED STUDY; EXON; GENE OVEREXPRESSION; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FOLDING; GENETICS; METABOLISM; SACCHAROMYCES CEREVISIAE; UBIQUITINATION;

AUTOPHAGY; CARRIER PROTEINS; CELL CYCLE PROTEINS; INCLUSION BODIES; LYSOSOMES; NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN FOLDING; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; UBIQUITIN; UBIQUITINATION; UBIQUITINS; VACUOLES;

EID: 84976537435     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E16-01-0026     Document Type: Article

References (56)

1. Ammerer G, Hunter CP, Rothman JH, Saari GC, Valls LA, Stevens TH (1986). PEP4 gene of Saccharomyces cerevisiae encodes proteinase A, a vacuolar enzyme required for processing of vacuolar precursors. Mol Cell Biol 6, 2490-2499.
2. Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S, Starr E, Squitieri F, Lin B, Kalchman MA, et al. (1993). The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet 4, 398-403.
3. Bhat KP, Yan S, Wang CE, Li S, Li XJ (2014). Differential ubiquitination and degradation of huntingtin fragments modulated by ubiquitin-protein ligase E3A. Proc Natl Acad Sci USA 111, 5706-5711.
4. Ceballos-Diaz C, Rosario AM, Park HJ, Chakrabarty P, Sacino A, Cruz PE, Siemienski Z, Lara N, Moran C, Ravelo N, et al. (2015). Viral expression of ALS-linked ubiquilin-2 mutants causes inclusion pathology and behavioral deficits in mice. Mol Neurodegener 10, 25.
5. Chang HC, Nathan DF, Lindquist S (1997). In vivo analysis of the Hsp90 cochaperone Sti1 (p60). Mol Cell Biol 17, 318-325.
6. Chin LS, Olzmann JA, Li L (2010). Parkin-mediated ubiquitin signalling in aggresome formation and autophagy. Biochem Soc Trans 38, 144-149.
7. Chiti F, Dobson CM (2006). Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75, 333-366.
8. Ciechanover A, Kwon YT (2015). Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med 47, e147.
9. Daniel JA, Yoo J, Bettinger BT, Amberg DC, Burke DJ (2006). Eliminating gene conversion improves high-throughput genetics in Saccharomyces cerevisiae. Genetics 172, 709-711.
10. Daoud H, Rouleau GA (2011). A role for ubiquilin 2 mutations in neurodegeneration. Nat Rev Neurol 7, 599-600.
11. Deng HX, Chen W, Hong ST, Boycott KM, Gorrie GH, Siddique N, Yang Y, Fecto F, Shi Y, Zhai H, et al. (2011). Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 477, 211-215.
12. Doi H, Mitsui K, Kurosawa M, Machida Y, Kuroiwa Y, Nukina N (2004). Identification of ubiquitin-interactiong proteins in purified polyglutamine aggregates. FEBS Lett 571, 171-176.
13. Duennwald ML, Jagadish S, Muchowski PJ, Lindquist S (2006). Flanking sequences profoundly alter polyglutamine toxicity in yeast. Proc Natl Acad Sci USA 103, 11045-11050.
14. Elsasser S, Finley D (2005). Delivery of ubiquitinated substrates to protein-unfolding machines. Nat Cell Biol 7, 742-749.
15. Gong H, Romanova NV, Allen KD, Chandramowlishwaran P, Gokhale K, Newnam GP, Mieczkowski P, Sherman MY, Chernoff YO (2012). Polyglutamine toxicity is controlled by prion composition and gene dosage in yeast. PLoS Genet 8, e1002634.
16. Hartl FU, Bracher A, Hayer-Hartl M (2011). Molecular chaperones in protein folding and proteostasis. Nature 475, 324-332.
17. Heinen C, Acs K, Hoogstraten D, Dantuma NP (2011). C-terminal UBA domains protect ubiquitin receptors by preventing initiation of protein degradation. Nat Commun 2, 191.
18. Heir R, Ablasou C, Dumontier E, Elliott M, Fagotto-Kaufmann C, Bedford FK (2006). The UBL domain of PLIC-1 regulates aggresome formation. EMBO Rep 7, 1252-1258.
19. Husnjak K, Elsasser S, Zhang N, Chen X, Randles L, Shi Y, Hofmann K, Walters KJ, Finley D, Dikic I (2008). Proteasome subunit Rpn13 is a novel ubiquitin receptor. Nature 453, 481-488.
20. Kalchman MA, Graham RK, Xia G, Koide HB, Hodgson JG, Graham KC, Goldberg YP, Gietz RD, Pickart CM, Hayden MR (1996).Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme. J Biol Chem 271, 19385-19394.
21. Kang Y, Vossler RA, Diaz-Martinez LA, Winter NS, Clarke DJ, Walters KJ (2006). UBL/UBA ubiquitin receptor proteins bind a common tetraubiquitin chain. J Mol Biol 356, 1027-1035.
22. Krobitsch S, Lindquist S (2000). Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc Natl Acad Sci USA 97, 1589-1594.
23. Kroemer G, Marino G, Levine B (2010). Autophagy and the integrated stress response. Mol Cell 40, 280-293.
24. Lajoie P, Snapp EL (2010). Formation and toxicity of soluble polyglutamine oligomers in living cells. PLoS One 5, e15245.
25. Lassle M, Blatch GL, Kundra V, Takatori T, Zetter BR (1997). Stress-inducible, murine protein mSTI1. Characterization of binding domains for heat shock proteins and in vitro phosphorylation by different kinases. J Biol Chem 272, 1876-1884.
26. Li M, Rong Y, Chuang YS, Peng D, Emr SD (2015). Ubiquitin-dependent lysosomal membrane protein sorting and degradation. Mol Cell 57, 467-478.
27. Liu C, Apodaca J, Davis LE, Rao H (2007). Proteasome inhibition in wild-type yeast Saccharomyces cerevisiae cells. Biotechniques 42, 158160, 162.
28. Longtine MS, McKenzie A 3rd, Demarini DJ, Shah NG, Wach A, Brachat A, Philippsen P, Pringle JR (1998). Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae. Yeast 14, 953-961.
29. Lowe ED, Hasan N, Trempe JF, Fonso L, Noble ME, Endicott JA, Johnson LN, Brown NR (2006). Structures of the Dsk2 UBL and UBA domains and their complex. Acta Crystallogr D Biol Crystallogr 62, 177-188.
30. Lu K, Psakhye I, Jentsch S (2014a). Autophagic clearance of polyQ proteins mediated by ubiquitin-Atg8 adaptors of the conserved CUET protein family. Cell 158, 549-563.
31. Lu K, Psakhye I, Jentsch S (2014b). A new class of ubiquitin-Atg8 receptors involved in selective autophagy and polyQ protein clearance. Autophagy 10, 2381-2382.
32. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, et al. (1996). Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506.
33. Matiuhin Y, Kirkpatrick DS, Ziv I, Kim W, Dakshinamurthy A, Kleifeld O, Gygi SP, Reis N, Glickman MH (2008). Extraproteasomal Rpn10 restricts access of the polyubiquitin-binding protein Dsk2 to proteasome. Mol Cell 32, 415-425.
34. Mende-Mueller LM, Toneff T, Hwang SR, Chesselet MF, Hook VY (2001). Tissue-specific proteolysis of Huntingtin (htt) in human brain: evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum. J Neurosci 21, 1830-1837.
35. Meriin AB, Zhang X, He X, Newnam GP, Chernoff YO, Sherman MY (2002). Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1. J Cell Biol 157, 997-1004.
36. Muchowski PJ, Schaffar G, Sittler A, Wanker EE, Hayer-Hartl MK, Hartl FU (2000). Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. Proc Natl Acad Sci USA 97, 7841-7846.
37. Ohno A, Jee J, Fujiwara K, Tenno T, Goda N, Tochio H, Kobayashi H, Hiroaki H, Shirakawa M (2005). Structure of the UBA domain of Dsk2p incomplex with ubiquitin molecular determinants for ubiquitin recognition. Structure 13, 521-532.
38. Osaka M, Ito D, Yagi T, Nihei Y, Suzuki N (2015). Evidence of a link between ubiquilin 2 and optineurin in amyotrophic lateral sclerosis. Hum Mol Genet 24, 1617-1629.
39. Rutherford NJ, Lewis J, Clippinger AK, Thomas MA, Adamson J, Cruz PE, Cannon A, Xu G, Golde TE, Shaw G, et al. (2013). Unbiased screen reveals ubiquilin-1 and -2 highly associated with huntingtin inclusions. Brain Res 1524, 62-73.
40. Steffan JS, Agrawal N, Pallos J, Rockabrand E, Trotman LC, Slepko N, Illes K, Lukacsovich T, Zhu YZ, Cattaneo E, et al. (2004). SUMO modification of Huntingtin and Huntington's disease pathology. Science 304, 100-104.
41. Stieren ES, El Ayadi A, Xiao Y, Siller E, Landsverk ML, Oberhauser AF, Barral JM, Boehning D (2011). Ubiquilin-1 is a molecular chaperone for the amyloid precursor protein. J Biol Chem 286, 35689-35698.
42. Takahashi T, Kikuchi S, Katada S, Nagai Y, Nishizawa M, Onodera O (2008). Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic. Hum Mol Genet 17, 345-356.
43. Takalo M, Salminen A, Soininen H, Hiltunen M, Haapasalo A (2013). Protein aggregation and degradation mechanisms in neurodegenerative diseases. Am J Neurodegener Dis 2, 1-14.
44. Taylor JP, Tanaka F, Robitschek J, Sandoval CM, Taye A, Markovic-Plese S, Fischbeck KH (2003). Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. Hum Mol Genet 12, 749-757.
45. Thompson LM, Aiken CT, Kaltenbach LS, Agrawal N, Illes K, Khoshnan A, Martinez-Vincente M, Arrasate M, O'Rourke JG, Khashwji H, et al. (2009). IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. J Cell Biol 187, 1083-1099.
46. Tong AH, Evangelista M, Parsons AB, Xu H, Bader GD, Page N, Robinson M, Raghibizadeh S, Hogue CW, Bussey H, et al. (2001). Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science 294, 2364-2368.
47. Toulmay A, Prinz WA (2013). Direct imaging reveals stable, micrometer-scale lipid domains that segregate proteins in live cells. J Cell Biol 202, 35-44.
48. Tyedmers J, Mogk A, Bukau B (2010). Cellular strategies for controlling protein aggregation. Nat Rev Mol Cell Biol 11, 777-788.
49. Varshavsky A (2012). The ubiquitin system, an immense realm. Annu Rev Biochem 81, 167-176.
50. Verma R, Oania R, Graumann J, Deshaies RJ (2004). Multiubiquitin chain receptors define a layer of substrate selectivity in the ubiquitin-proteasome system. Cell 118, 99-110.
51. Walker FO (2007). Huntington's disease. Semin Neurol 27, 143-150.
52. Walters KJ, Zhang N (2008). Rpn10 protects the proteasome from Dsk2. Mol Cell 32, 459-460.
53. Wang H, Monteiro MJ (2007). Ubiquilin interacts and enhances the degradation of expanded-polyglutamine proteins. Biochem Biophys Res Commun 360, 423-427.
54. Wang Y, Meriin AB, Zaarur N, Romanova NV, Chernoff YO, Costello CE, Sherman MY (2009). Abnormal proteins can form aggresome in yeast: aggresome-targeting signals and components of the machinery. FASEB J 23, 451-463.
55. Wen X, Klionsky DJ (2016). An overview of macroautophagy in yeast. J Mol Biol .
56. Yang J, Hao X, Cao X, Liu B, Nystrom T (2016). Spatial sequestration and detoxification of Huntingtin by the ribosome quality control complex. Elife 5, e11792.